Centers | ||
EU-OPENSCREEN | Drug Discovery Unit | FDA Oncology Center of Excellence Project Catalyst | 
EU-OPENSCREEN is a multinational, not-for-profit initiative, which 
integrates high-capacity screening platforms and chemistry groups across
 Europe. The aim of this initiative is to support individual scientists 
interested in chemical  biology...  | 
				The Drug Discovery Unit (DDU) is a fully integrated drug discovery group established to translate world-class biology research into novel drug targets and candidate drugs. Housed within purpose built facilities at the University of Dundee, the  DDU... Read more | 
				Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation  | 
					
Partnerships | 
						Events | 
						Jobs | 
					
							
							
							Astra Zeneca and University of Pennsylvania Partner to Develop Treatments to Manage ObesityAstra Zeneca has entered into a research collaboration agreement with University of Pennsylvania's Institute for Diabetes, Obesity and Metabolism to develop small and or large molecules to manage obesity, control glucose and lipid metabolism in... View all Merck Serono and Feinstein Institute to Develop New Drugs to Treat LupusMerck Serono and Feinstein Institute the research arm of North Shore-Long Island Jewish Health System in New York have entered into a joint collaboration to develop new antibody based therapies to treat Systemic Lupus Erythematosus (SLE). Merck... View all Pharma and Academia Consortium Partner to Develop New Drugs in EuropeA consortium of academic institutes from Germany, Britain, Netherlands and Denmark partner with a group of leading pharmaceutical companies which include AstraZeneca, Sanofi, Bayer, UCB , Lundbeck , Merck KGaA, and Janssen which is a JNJ... View all  | 
						
						 No EVENTS for listing  | 
						
								
 No Job Posts  | 
					


